Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement

Wasyla Ibrahim (Glasgow, United Kingdom), Wasyla Ibrahim, Megan Crichton, Alison Dicker, James Chalmers

Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Session: Bronchiectasis and NTM infections: clinical and functional characterisation
Session type: Thematic Poster Session
Number: 2630
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wasyla Ibrahim (Glasgow, United Kingdom), Wasyla Ibrahim, Megan Crichton, Alison Dicker, James Chalmers. Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement. Eur Respir J 2015; 46: Suppl. 59, 2630

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Multi-analyte profiling of inflammatory markers in COPD sputum
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Sputum processing methods in airway disease: Which is best?
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Prediction of CF exacerbations in children by exhaled inflammation markers
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Association between sputum cytology and lung function in patients with asthma and COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015


Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Pepsin as a reliable biomarker for reflux aspiration: A novel method for detection
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013

Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid
Source: International Congress 2014 – ILDs 1
Year: 2014


Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis
Source: International Congress 2015 – Paediatric bronchology
Year: 2015